Search results
Fact Check: Posts on Pfizer CEO calling COVID pandemic a rehearsal are misleading
Reuters· 1 day agoA 2023 quote from Pfizer CEO Albert Bourla describing the COVID-19 pandemic as a “rehearsal” has...
Pfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
Zacks via Yahoo Finance UK· 1 day agoPfizer (PFE) and BioNTech's Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal...
US drug giant Pfizer beats GSK to UK government contract for 4.9m vaccine shots
CityAM via Yahoo Finance UK· 4 days agoPfizer has beaten GSK to win a contract to supply millions of doses of a new respiratory vaccine in...
COVID summer guide: How to navigate symptoms, variants and vaccines this season amid rising cases
Yahoo Life· 4 days agoWho should wait and who should get vaccinated now? The CDC advises that everyone age 5 and older...
Is Pfizer Inc. (PFE) the Best Healthcare Stock to Buy Under $50?
Insider Monkey via Yahoo Finance UK· 2 days agoWe recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we...
Did Seagen Acquisition Help Pfizer Inc. (PFE) Increase Revenue in Q1?
Insider Monkey via Yahoo Finance UK· 5 days agoWe recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Hedge Funds. In...
UK Government Snubs GSK in Favor of Pfizer’s Rival RSV Shot
Bloomberg· 5 days agoHave a confidential tip for our reporters? GSK Plc has lost out to Pfizer Inc. on a contract to...
Pfizer And Five Other Dividend-Yield Standouts
Forbes· 6 days ago“Would you kindly do a piece on high dividend stocks,” a reader asked recently. My favorite high-divided stock at the moment is Pfizer Inc. (PFE). In my...
The GSK share price just tumbled (again). Is this FTSE 100 stock now a bargain?
Fool.co.uk via Yahoo Finance UK· 1 day agoMore bad news from across the pond has hit the GSK share price. But does an attractive valuation and...
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
Zacks via Yahoo Finance UK· 4 days agoPfizer (PFE) closed the latest trading day at $27.99, indicating a -1.3% change from the previous session's end. The stock fell short of the S&P 500,...